| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Russian Federation | 23 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Machines | |
| #5 | Measurement | |
| #6 | Organic fine chemistry | |
| #7 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Measuring microorganism processes | |
| #5 | Enzymes | |
| #6 | Unspecified technologies | |
| #7 | Analysing materials | |
| #8 | Climate change adaptation technologies | |
| #9 | Sugars | |
| #10 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Khorkova Sherman Olga | 23 |
| #2 | Kollard Dzhozef | 23 |
| #3 | Kojto Karlos | 5 |
| #4 | De Leon Belinda | 2 |
| #5 | Khsyao Dzhejn Kh Dr | 1 |
| #6 | Gang Shen | 1 |
| Publication | Filing date | Title |
|---|---|---|
| RU2611191C2 | Treatment of diseases, associated with sex hormones binding globulin (shbg), by inhibition of natural antisense transcript to shbg | |
| RU2615450C2 | Treating diseases associated with nuclear respiratory factor 1 (nrf1) by inhibition of natural antisense transcript to nrf1 | |
| RU2639550C2 | Treatment of diseases connected with site-1 membrane-impacted peptidase of transcription factors (mbtps1), by inhibiting natural antisense transcript to mbtps1 |